Bausch Health Companies Inc.

NYSE:BHC 株式レポート

時価総額：US$3.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Bausch Health Companies マネジメント

マネジメント 基準チェック /24

Bausch Health Companies'の CEO はTom Appioで、 May2022年に任命され、 の在任期間は 2.08年です。 の年間総報酬は$ 15.88Mで、 7.4%給与と92.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.11%を直接所有しており、その価値は$ 2.70M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と7.9年です。

主要情報

Tom Appio

最高経営責任者

US$15.9m

報酬総額

CEO給与比率7.4%
CEO在任期間2.3yrs
CEOの所有権0.1%
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間8.2yrs

経営陣の近況

Recent updates

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

Sep 19

Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

Aug 06
Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

2 Red Alerts On Bausch Health Companies

Jul 25

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation

Feb 24

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Nov 30

Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Nov 01
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics

Sep 24

Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Jul 24
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes

Jul 06

What To Do After Bausch Health Stock Plunged By Nearly 9% Again

Jun 07

Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Apr 18
Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out

Dec 30

Bausch Health acne lotion Arazlo available in Canada under public drug plans

Dec 22

Bausch Health: Things To Consider Before Investing

Dec 11

Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Nov 10
Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Bausch Health Companies Q3 2022 Earnings Preview

Nov 02

Bausch Health: Long-Term Need To Place Stops For Protection

Sep 28

Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff

Sep 21

CEO報酬分析

Bausch Health Companies の収益と比較して、Tom Appio の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$471m

Mar 31 2024n/an/a

-US$455m

Dec 31 2023US$16mUS$1m

-US$592m

Sep 30 2023n/an/a

-US$963m

Jun 30 2023n/an/a

-US$186m

Mar 31 2023n/an/a

-US$357m

Dec 31 2022US$13mUS$1m

-US$225m

Sep 30 2022n/an/a

US$254m

Jun 30 2022n/an/a

US$43m

Mar 31 2022n/an/a

-US$407m

Dec 31 2021US$10mUS$854k

-US$948m

Sep 30 2021n/an/a

-US$1b

Jun 30 2021n/an/a

-US$1b

Mar 31 2021n/an/a

-US$1b

Dec 31 2020US$4mUS$775k

-US$560m

Sep 30 2020n/an/a

-US$2b

Jun 30 2020n/an/a

-US$2b

Mar 31 2020n/an/a

-US$2b

Dec 31 2019US$4mUS$769k

-US$2b

Sep 30 2019n/an/a

-US$616m

Jun 30 2019n/an/a

-US$917m

Mar 31 2019n/an/a

-US$2b

Dec 31 2018US$4mUS$730k

-US$4b

Sep 30 2018n/an/a

-US$3b

Jun 30 2018n/an/a

-US$2b

Mar 31 2018n/an/a

-US$805m

Dec 31 2017US$3mUS$650k

US$2b

報酬と市場: Tomの 総報酬 ($USD 15.88M ) は、 US市場 ($USD 5.66M ) の同規模の企業の平均を上回っています。

報酬と収益: Tomの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Tom Appio (62 yo)

2.3yrs

在職期間

US$15,878,578

報酬

Mr. Thomas J. Appio, also known as Tom, serves as the Chief Executive Officer & Director at Bausch Health Companies Inc. and served as Chief Executive Officer of Pharma Business and served as President & C...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Thomas Appio
CEO & Director2.3yrsUS$15.88m0.12%
$ 3.6m
Seana Carson
Executive VP & General Counsel2.3yrsUS$3.16m0.035%
$ 1.1m
Jean-Jacques Charhon
Chief Financial Officerless than a yearデータなしデータなし
Mirza Dautbegovic
Executive VP & COO2.7yrsデータなし0.035%
$ 1.1m
Kathleen Fitzpatrick
Executive VP and Chief HR & Communications Officer2.7yrsデータなしデータなし
Tage Ramakrishna
Chief Medical Officer and President of R&Dno dataデータなしデータなし
Jeff Hartness
Executive VP of Market Access4.3yrsデータなしデータなし
Cees Heiman
Senior Vice President of Europe & Canada2.7yrsデータなしデータなし
Donald Pearl
Senior Vice President of Ortho Dermatologicsno dataデータなしデータなし
Jiny Kim
Senior Vice President of Solta Medical1.7yrsデータなしデータなし
Aimee Lenar
Executive Vice President of US Pharmaless than a yearデータなしデータなし
William Woodfield
Senior VP & Treasurerno dataデータなしデータなし

2.3yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: BHCの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Thomas Appio
CEO & Director2.3yrsUS$15.88m0.12%
$ 3.6m
John Paulson
Independent Chairman2.3yrsUS$812.50k0.000060%
$ 1.8k
Robert Power
Independent Director16.1yrsUS$389.55k0.0018%
$ 54.6k
H. Fibiger
Chairman of External Advisory Boardno dataUS$2.00mデータなし
Sarah Kavanagh
Independent Director8.2yrsUS$718.28k0%
$ 0
Robert Lenox
Member of the External Advisory Board15.5yrsデータなしデータなし
Kathleen Clarence-Smith
Member of the External Advisory Board15.5yrsデータなしデータなし
Karoly Nikolich
Member of the External Advisory Board15.5yrsデータなしデータなし
Brett Icahn
Independent Director3.5yrsUS$691.72k0.00020%
$ 6.1k
Amy Wechsler
Independent Director8.3yrsUS$377.50k0.011%
$ 348.1k
Steven Miller
Independent Director3.5yrsUS$381.31k0.031%
$ 932.4k
Christian Garcia
Independent Directorless than a yearデータなしデータなし

8.2yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: BHCの 取締役会 は 経験豊富 であると考えられます ( 7.9年の平均在任期間)。